CSPC Pharmaceutical Group (OTCMKTS:CSPCY) Shares Up 1.1% – Should You Buy?

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCYGet Free Report) was up 1.1% during trading on Tuesday . The company traded as high as C$4.68 and last traded at C$4.68. Approximately 2,178 shares were traded during trading, a decline of 91% from the average daily volume of 24,011 shares. The stock had previously closed at C$4.63.

CSPC Pharmaceutical Group Trading Up 1.1%

The business has a 50 day simple moving average of C$5.12 and a two-hundred day simple moving average of C$4.23.

About CSPC Pharmaceutical Group

(Get Free Report)

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.

Recommended Stories

Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.